Implications of first-line adjuvant treatment with aromatase inhibitors in recurrent metastatic breast cancer

Lisa E. Sokolowicz, William J. Gradishar*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Implications of first-line adjuvant treatment with aromatase inhibitors in recurrent metastatic breast cancer'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science